CD-001

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameCD-001
Drug Alias NameCD-001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed cell death protein 1 blockersInterleukin-21 replacements
TargetsProgrammed cell death protein 1Interleukin-21
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsHead and Neck Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCD (Suzhou) Biopharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBioCorteX LtdCD (Suzhou) Biopharma Co LtdWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsHead and Neck Neoplasms +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A